Pickett: Alzheimer’s drug results ‘most detailed and promising’ yet…
New research focusing on the aducanumab drug –which is an antibody developed to target the amyloid protein; one of the hallmarks of Alzheimer’s – has indicated that a drug can discard the protein from individuals in the early stages of the disease. 165 people with early or mild stages of Alzheimer’s disease participated in the […]
